Anna Louie, M.D.
Assistant Professor, Surgery
Professional Background
Dr. Anna D. Louie is a Breast Surgical Oncologist and Assistant Professor of Surgery at the University of Kansas Medical Center. Dr. Louie is board-certified by the American Board of Surgery. Dr. Louie completed her undergraduate training at Brown University and medical school at the University of Nevada, Reno School of Medicine, during which she was a research scholar at the National Institutes of Health. Dr. Louie then completed general surgery residency at Brown University and Duke University. She continued her training in Breast Surgical Oncology at Duke University. Dr. Louie has received multiple teaching and research awards.
Dr. Louie's practice is dedicated to breast oncology patients and breast disease. She is trained in advanced surgical techniques, including oncoplastic surgery, breast conservation, nipple- and skin-sparing mastectomy, and advanced axillary surgical approaches, including offering reverse lymphatic mapping and targeted axillary dissection. In addition, she has experience with benign breast disease and works with uncommon breast malignancies such as malignant phyllodes and breast angiosarcoma. Dr. Louie has a specific interest in the care of patients with advanced and metastatic disease as well as in lobular carcinoma of the breast.
Education and Training
- BS, Biology with a focus in Immunobiology, Brown University, Providence, RI
- MD, Doctor of Medicine, Reno School of Medicine University of Nevada, Reno, NV
- Residency, General Surgery Resident, Brown University, Providence, RI
- Residency, Surgery, Duke University, Durham, NC
- Post Doctoral Fellowship, Breast Surgical Oncology, Duke, Durham, NC
Licensure, Accreditations & Certifications
- General Surgery, ABS’s Continuous Certification Program
Research
Overview
Dr. Louie has extensive research experience in basic and translational research with a record of impactful publications and patents. Her research focuses on organ-specific variation in genomic signatures of breast cancer metastases, and how those differences may be used to predict sites of metastasis and responses to therapy.